JP Morgan Chase
CANO

JP Morgan Chase’s Cano Health, Inc. CANO Stock Holding History

JP Morgan Chase’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,704
Closed -$10K – 8107
2023
Q4 		$10K Buy
1,704
+137
+9% +$1.62K ﹤0.01% 6403
2023
Q3 		$39.7K Sell
1,567
-155,720
-99% -$12.8M ﹤0.01% 5866
2023
Q2 		$21.9M Sell
157,287
-1,658
-1% -$213K ﹤0.01% 1634
2023
Q1 		$14.5M Sell
158,945
-4,804
-3% -$652K ﹤0.01% 1938
2022
Q4 		$22.4M Buy
163,749
+4,884
+3% +$1.65M ﹤0.01% 1584
2022
Q3 		$138M Sell
158,865
-2,740
-2% -$1.72M 0.02% 611
2022
Q2 		$70.8M Buy
161,605
+61,860
+62% +$32.3M 0.01% 887
2022
Q1 		$63.3M Buy
99,745
+45,763
+85% +$28.9M 0.01% 1050
2021
Q4 		$48.1M Buy
+53,982
New +$56.7M 0.01% 1231
2021
Q1 		– Sell
-1,708
Closed -$2.29M – 6458
2020
Q4 		$2.29M Buy
+1,708
New +$1.95M ﹤0.01% 3383

Other funds holding CANO

SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GFPC
Global Financial Private Client Sarasota, Florida $369M AUM 34.4% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
CP
Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return

JP Morgan Chase's CANO Position: Q1 2024 in Review

JP Morgan Chase sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 1,704 shares — an estimated $10K sold.

JP Morgan Chase first reported a position in CANO in Q4 2020 and held it in 10 quarters. The position peaked at $138M in Q3 2022. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • JP Morgan Chase reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 1,704 Cano Health, Inc. shares in Q1 2024, an estimated $10K.
  • JP Morgan Chase first reported a position in Cano Health, Inc. in Q4 2020 and held it in 10 quarters.
  • JP Morgan Chase's Cano Health, Inc. position peaked at $138M in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.